+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Serum from patients with multiple sclerosis downregulates occludin and VE-cadherin expression in cultured endothelial cells



Serum from patients with multiple sclerosis downregulates occludin and VE-cadherin expression in cultured endothelial cells



Multiple Sclerosis 9(3): 235-238



Disruption of the blood-brain barrier (BBB) and transendothelial migration of inflammatory cells are crucial steps in the development of demyelinating lesions in multiple sclerosis (MS). Occludin and vascular endothelial-cadherin (VE-cadherin) are two major components of the tight junctions (TJs) in the brain microvasculature that help to create the BBB. In the present study, we investigated the effect of serum from MS patients on the expression of these two junctional markers and on the endothelial integrity. Serum from six MS patients in exacerbation, six in remission, and six normal controls (10% by volume) was incubated with cultured endothelial cells, and the expression of occludin and VE-cadherin was measured by immunoblotting. Serum from MS patients in exacerbation significantly reduced the expression of occludin and VE-cadherin compared with patients in remission and normal controls. This disintegrating effect was more pronounced for occludin than for VE-cadherin. We assume that the elevation in cytokines or other serum-soluble factors in MS patients in exacerbation likely provokes downregulation of occludin and VE-cadherin. This downregulation of TJs proteins may, therefore, contribute to the disruption of the BBB in this condition.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011348345

Download citation: RISBibTeXText

PMID: 12814168

DOI: 10.1191/1352458503ms916oa


Related references

HIV-1 Tat protein increases the permeability of brain endothelial cells by both inhibiting occludin expression and cleaving occludin via matrix metalloproteinase-9. Brain Research 1436: 13-19, 2012

Lypopolysaccharide downregulates the expression of selected phospholipase C genes in cultured endothelial cells. Inflammation 36(4): 862-868, 2013

Probucol downregulates E-selectin expression on cultured human vascular endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 16(8): 1047-1051, 1996

Junctional localization of occludin and N-cadherin in rat mesenteric microlymphatic endothelial cells. FASEB Journal 14(4): A8, 2000

Effect of blood serum from patients with multiple sclerosis on the genetic apparatus of cultured cells. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 72(12): 1797-1800, 1972

TGF- beta 1 downregulates inflammatory cytokine induced VCAM-1 expression in cultured human glomerular endothelial cells. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 483A, 1998

Shear increases occludin phosphorylation and decreases occludin content in cultured endothelial monolayers. FASEB Journal 13(4 Part 1): A3, 1999

Destruction of nerve cells cultured "in vitro" by lymphocytes from patients with multiple sclerosis. Auto-immune pathogenesis of multiple sclerosis. La Presse Medicale 77(55): 2103-2106, 1969

Sodium phenyl butyrate downregulates endothelin-1 expression in cultured human endothelial cells: relevance to sickle-cell disease. American Journal of Hematology 82(5): 357-362, 2007

Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content. Vascular endothelial growth factor decreases occludin in retinal endothelial cells. Diabetes 47(12): 1953-1959, 1998

Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 47(12): 1953-1959, 1998

Transforming growth factor-beta1 downregulates caveolin-1 expression and enhances sphingosine 1-phosphate signaling in cultured vascular endothelial cells. American Journal of Physiology. Cell Physiology 297(5): C1263-C1274, 2009

Serum concentration of soluble E-cadherin (sE-cadherin) and beta-catenin expression in leukemic cells in acute myeloblastic leukemia (AML) patients. Acta Haematologica Polonica 37(3): 351-359, 2006

Interferon-beta therapy downregulates the anti-apoptosis protein FLIP in T cells from patients with multiple sclerosis. Journal of Neuroimmunology 120(1-2): 199-207, 2001